|
Microbiology, Immunology & Infectious Diseases
Friday, October 4, 2013 | 8:30 AM - 4:30 PM | Symbioses between humans and our gut microbiome influence human biology including nutrition, immune function, and brain development. We review how symbiotic relationships impact drug metabolism and development, and a variety of disease states. More
This eBriefing presents the Sackler Institute's Global Research Agenda for Nutrition Science, developed in collaboration with the World Health Organization and global nutrition experts. More
This Annals volume presents papers that discuss progress of immunology research toward the development of cancer vaccines. More
-
June 19 - 20, 2013
Conference Planning Committee: Claudio Carini (Pfizer Inc.), Teresa Compton (Biogen Idec (Conference Chair)), Marion Kasaian (Pfizer Inc.), Theodora Salcedo (Bristol-Myers Squibb Company), Anne Vogt (F. Hoffmann-La Roche Ltd)
Scientific Advisory Board: Leonard Calabrese (Cleveland Clinic), Paola Cinque (Hospital San Raffaele), David Clifford (Washington University School of Medicine), Robert Garcea (University of Colorado at Boulder), Eugene Major (National Institute of Neurological Disorders and Stroke), Kenneth Tyler (University of Colorado Anschutz Medical Campus), Thomas Weber (University of Hamburg)
New basic science and clinical findings relevant to the pathogenesis, mitigation, cure, and risk stratification of Progressive Multifocal Leukoencephalopathy will support a discussion of current challenges and future directions for PML treatment.
Monday, June 24, 2013 | 10:30 AM - 3:00 PM
Speakers: Yasmine Belkaid (National Institute of Allergy and Infectious Diseases, NIH), Dan R. Littman (New York University School of Medicine), Alexander Rudensky (Memorial Sloan-Kettering Cancer Center)
The Ross Prize, established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine, is awarded to an investigator producing innovative, paradigm-shifting research worthy of significant attention in molecular medicine.
Tuesday, September 24, 2013 | 8:30 AM - 4:30 PM
Speakers: Karin Bornfeldt (University of Washington School of Medicine), Elena V. Galkina (Eastern Virginia Medical School), Emmanuel L. Gautier (Washington University School of Medicine, St. Louis), Klaus Ley (La Jolla Institute for Allergy and Immunology), Andrew H. Lichtman (Brigham and Women's Hospital, Harvard Medical School), Kathryn J. Moore (New York University Medical Center), Matthias Nahrendorf (Harvard Medical School), Alan R. Tall (Columbia University Medical Center)
Currently available therapies fail to resolve the full burden of many cardiovascular diseases. Understanding the role of key hematopoietic and inflammatory players in this disease process may help identify new targets for fighting atherosclerosis.
Friday, October 4, 2013 | 8:30 AM - 4:30 PM
Speakers: David Artis (University of Pennsylvania), Stephen M. Collins (McMaster University), Michael A. Fischbach (University of California, San Francisco), Dirk Gevers (The Broad Institute of MIT and Harvard), Jeremy K. Nicholson (Imperial College London), Lita M. Proctor (National Human Genome Research Institute, NIH)
Symbioses between humans and our gut microbiome influence human biology including nutrition, immune function, and brain development. We review how symbiotic relationships impact drug metabolism and development, and a variety of disease states. This symposium features a poster session.
Wednesday, June 12, 2013 | 7:45 AM - 6:00 PM
In-house event is SOLD OUT! Register for the live webinar.
Speakers: Martin J. Blaser (New York University School of Medicine), Sir Harry Burns (Scottish Government, Scotland), Patrice D. Cani (Université Catholique de Louvain, Belgium), Fred H. Degnan (King & Spalding LLP), Joël Doré (Institut National de la Recherche Agronomique, France), Jane A. Foster (McMaster University, Canada), Gary Frost (Imperial College London, United Kingdom), Patricia L. Hibberd (Harvard Medical School / Massachusetts General Hospital for Children), John Hutton (University of York, United Kingdom), Todd Klaenhammer (North Carolina State University), David A. Mills (University of California, Davis), Max Nieuwdorp (University of Amsterdam, The Netherlands), Bruno Pot (Institut Pasteur de Lille, France), Rowena Pullan (Pfizer Consumer Healthcare), Helen E. Raybould (University of California, Davis), Gregor Reid (Western University / Lawson Health Research Institute, Canada), David A. Relman (Stanford University School of Medicine), Andrew Serazin (Matatu LLC)
Explore research and policy strategies to translate scientific knowledge on the convergence of the microbiome, prebiotics, probiotics, and host physiology into nutritional and therapeutic applications for inflammation, obesity, diabetes, gastrointestinal disease, and malnutrition.
Thursday, May 30, 2013 | 9:00 AM - 5:00 PM
Review progress on key aspects of the Plasmodium vivax research agenda as they pertain to malaria treatment, control, and elimination through a series of free, interdisciplinary workshops.
May 28 - 29, 2013 | Spain
Explore Plasmodium vivax biology and genomics; drug resistance and discovery; and recent clinical trial and in-field efforts in P. vivax malaria prevention, treatment, control, and elimination.
Friday, May 24, 2013 | 8:30 AM - 4:30 PM
Speakers: Scott A. Armstrong (Memorial Sloan-Kettering Cancer Center), Stephen Baylin (The Johns Hopkins University School of Medicine), Robert A. Copeland (Epizyme, Inc.), Vicki L. Goodman (GlaxoSmithKline), Haitao Li (Tsinghua University, China), X. Shirley Liu (Dana-Farber Cancer Institute), Robert Sims (Constellation Pharmaceuticals, Inc.), Alexander Tarakhovsky (The Rockefeller University)
Epigenetic research has shown that heritable changes in cancer cell transformation occur beyond the primary DNA sequence. This symposium reviews epigenetic regulators in cancer development and progress in designing therapies targeting the epigenome.
|
-
Annals
Edited by Noel R. Rose (The Johns Hopkins University, Baltimore, Maryland)
The fifth installment of The Year in Immunology series focuses on research in human immunology.
Volume 1285
eBriefing
Organizers: Johanne Morne (New York State Department of Health AIDS Institute), Sonja Noring (New York State Department of Health AIDS Institute), Cheryl Smith (New York State Department of Health AIDS Institute), AIDS Institute Social Media Workgroup (New York State Department of Health AIDS Institute), Brooke Grindlinger (The New York Academy of Sciences), and Kerstin Hofmeyer (The New York Academy of Sciences)
This eBriefing looks at the impact of digital technologies on clinical care, especially for HIV and other sexually transmitted infections, exploring eHealth strategies for patient-centered care and clinical decision support.
Annals
Edited by Olivera J. Finn (University of Pittsburgh, Pittsburgh, Pennsylvania) and Gerold Schuler (University Hospital of Erlangen, Erlangen, Germany)
This Annals volume presents papers that discuss progress of immunology research toward the development of cancer vaccines.
Annals
Edited by Narinder K. Mehra (All India Institute of Medical Sciences, New Delhi, India)
This Annals volume presents papers from the fifth congress of the Federation of Immunological Societies of Asia-Oceania.
Volume 1283
Delve into the world of prebiotic and probiotic science. We talk to three people in the field and learn why keeping the good microbes in our bodies happy means a lot for health.
Webinar Archive
March 2, 2010
Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.
Translational Medicine Initiative
 The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.
|
|
|